[RESEND] GLP Weekly: Public supports CRISPR, gene drives despite activist opposition; Did flawed bioterror plot doom ‘Designated Survivor’?; and more!

GLP Features Articles by GLP staff and contributors

Viewpoint: Public supports CRISPR, gene drives to battle infectious disease, plant pests—despite activist opposition Andrew Porterfield Did a ‘flawed’ bioterror plot doom Netflix’s ‘Designated Survivor’? Ricki Lewis Viewpoint: How the ‘Food Justice’ movement hinders progress toward equity, health, sustainability Margot Finn Length matters? DNA testing companies claim to assess stress, health and aging by measuring your telomeres Elise Fouquerel, Patricia Opresko Viewpoint: GMO, CRISPR-edited crops can cut pesticide use—if environmental activists do not block them Cameron English Artificial intelligence could revolutionize health care, but there’s no guarantee that will be a good thing Jeremy Hsu Viewpoint: Organic industry anti-pesticide ‘propaganda’ threatens to cripple American agriculture Henry Miller Podcast: GMO rice could yield affordable treatment to stem HIV in developing world Evangelia Vamvaka, Kevin Folta, Michelle Wu Viewpoint: Hidden conflicts of interest cripple IARC’s biased glyphosate-cancer evaluation David Zaruk New weapon in the fight against antibiotic resistance: Tricking bacteria ‘into killing themselves’ Molly Sargen